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inTRODUCTiOn
Mobile technologies and music are recognized as opportunities to address mental health challenges 
(1–3), while clinical and economic benefits of mobile health (mHealth) are currently studied (4–6). 
Herein, we describe feasibility of repurposing music streaming services as therapies for affective 
disorders. According to the World Health Organization, there are 350 million people worldwide 
suffering from depression, and 60 million people living with bipolar disorder. Patients with affective 
disorders such as depression, anxiety, or bipolar spectrum, and their caregivers are challenged with 
managing disease symptoms, long-term treatments, and disabilities. Between 1990 and 2010, there 
has been a 41% increase in public health burden of mental, neurological, and substance use disorders, 
as measured by disability-adjusted life years (7). Depression accounts for 40.5% of total disability-
adjusted life years among mental and substance-use disorders, whereas anxiety and bipolar disorder 
account for 14.6 and 7%, respectively (8). A long-term morbidity in bipolar spectrum disorders 
emphasizes the needs to improve treatments for depression (9). Treatments of affective disorders 
include mainly antidepressant, antipsychotic medications, and cognitive behavioral therapy (CBT). 
The efficacy of antidepressants for children and adolescent patients (10), medication adherence, and 
limited access to CBT in many countries continue to be a challenge for public health.
Treatments of depression, anxiety, and bipolar symptoms comprise CBT, psychosocial, and 
self-care interventions, also delivered via online and digital technologies (7, 11, 12). Opportunities 
for developing mobile apps and web-based interventions for neurological and mental disorders 
are economically feasible and coincide with the global adoption rates for smartphones (6, 13–16). 
Promising findings from clinical testing of mobile apps, e.g., in depression (17), are accompanied by 
challenges in patient engagement (18) and alignment of clinical and digital contents (19). Converting 
a mobile phone into low-cost virtual reality devices (exemplified by a Google VR cardboard) 
extends its potential medical applications (20, 21). Growing number of health-related wearables 
and devices measuring electrodermal activity (EDA), heart rate variability, or mobile electroen-
cephalogram (EEG) systems, expand the use of digital technologies in medicine, including mental 
health [a 5-week treatment with EEG-based musical neurofeedback improved depression scores by 
17% (22)]. Companies like Apple, Samsung, LG, Microsoft, Fitbit, Empatica, Emotiv, NeuroSky, or 
Muse develop smart watches and mobile EEG systems with health/wellness applications, whereas 
WellDoc, Akili Interactive, or Pear Therapeutics are engaged in converting mobile apps and games 
into medical device-based therapies for specific chronic diseases. Given accessibility of smartphones 
and the internet, we discuss opportunities for music streaming services to be developed as adjunct 
FiGURE 1 | Music streaming services as adjunct therapies for depression, anxiety, and bipolar symptoms by modulating arousal and valence. 
(A) A valence-arousal plane illustrating types of emotion-related music. Characteristics in the four categories of music were selected from listening to mood-related 
music streaming services and searching for similarities in musical pieces classified by the music provider as similar within the same categories. (B) Schematic 
organization of a music streaming service as an adjunct therapy for patients with depression, anxiety, or bipolar spectrum disorders. Streaming server contains 
millions of musical tracks grouped into a wide selection of genres. Internet and mobile devices, such as smartphones, serve as the delivery system. After a listener 
selects the preferred type of music, the software algorithm generates a playlist for streaming clinically beneficial “dose” of music with positive valence and activating 
arousal. Hypothetical values express percent of time/songs with music activating arousal per day; these values can be determined for individual medical conditions 
(depression, bipolar, and anxiety). The streamed musical content is further optimized for target valence/arousal by interplay between the streaming software 
algorithm and the listener’s preferences and biofeedback (also contributing to outcomes and mitigating bias in clinical trials). Double-headed arrows emphasize the 
flow of music and the feedback mechanism. Rigorous testing of the clinical efficacy of music streaming software (green box) in randomized clinical trials is necessary 
to develop and validate the music streaming therapy.
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therapies and prevention of depressive, anxiety, and bipolar 
spectrum symptoms.
EMOTiOnS AnD MUSiC STREAMinG 
SERViCES
Music modulates emotions by engaging several neurotransmitters 
and brain structures (2, 3, 23), including the brain’s reward and 
dopaminergic systems (24, 25). Music-induced emotions include 
happiness, relaxation, sadness, nostalgia, arousal, surprise, or irri-
tation (Figure 1A). The relationships between musical structures 
and emotions are complex and can be described in terms of the 
BRECVEM mechanism (Brain stem reflexes, rhythmic entrain-
ment, evaluative conditioning, contagion, visual imagery, episodic 
memory, and musical expectancy) (26). Music components such 
as tempo, dynamics, low/high pitches, satisfying rhythm, minor/
major key, or instrumentation can change listeners’ arousal and 
valence, impacting her/his overall mood (Figure  1A). Music-
induced emotional arousal and pleasure can be enhanced by 
expectation and predictability (27). Musical anticipation, specific 
rhythmic units, tempo, lyrics, and voice can affect arousal (28–30). 
Noteworthy, the musical harmony can contribute to intercultural 
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differences in music perception (31). Specific musical structures 
such as those in the Mozart’s Sonata K.448 were found to activate 
parasympathetic nervous system and to reduce the frequency of 
seizures and epileptiform discharges in epilepsy patients (32), 
and these antiseizure effects were observed in pediatric and adult 
patients across western and eastern cultures. The rhythm of the 
K.448 piece appeared to be one of key “active” structures, as deter-
mined by comparing it with the retrograde version of K.448 (33). 
Positive emotional effects of music were measured using plasma 
oxytocin and vasopressin levels, pointing to connections between 
the neuroendocrine system, music, and emotions (34). Music can 
modulate emotional circuitry in patients with major depressive 
disorder (35) and music listening for at least 3 weeks can reduce 
depressive symptoms, with some randomized controlled studies 
reporting 19–47% improvements in depression scores (36, 37).
Music streaming services such as Amazon Prime Music, Apple 
Music, Google Play Music, iHeartRadio, Pandora, Spotify, or 
SoundCloud play a variety of songs on-demand via the Internet 
and according to the user’s interests and preferences. A person 
can select music stations based on specific songs, artists, genres, 
or mood of a song. The station then plays songs, which the lis-
tener already selected, as well as new songs, which are similar to 
previous songs played. Music streaming services offer millions 
of songs and musical tracks and are available worldwide, or in 
selected countries. Many stations offer mood-based categories, 
for example Spotify (“Have a Great Day,” “Mood Booster,” “Calm 
Down,” “Good Vibes,” etc.) and Apple Music (“Get Happy,” “100 
Most Uplifting Songs Ever”) have preset playlists to choose, while 
Google Play Music (“Confident,” “Calm,” “Energetic,” etc.), Getty 
Images (“Up/Positive,” “Inspirational,” etc.), and Aupeo (“Happy,” 
“Dramatic,” “Relaxing,” etc.) have search criteria using mood to 
find specific music. Musicovery, another music streaming service, 
has a unique interactive interface similar to the arousal/valence 
plane (Figure  1A), in which the user can choose specifically 
what mood of music they would like. Music streaming services 
are compatible with Android and iOS operating platforms and 
include music video streaming like Vimeo or YouTube.
We hypothesize that digital and mobile technologies have 
advanced enough for repurposing music streaming service into a 
therapy for affective disorders by modulating arousal and valence 
via music-evoked emotions. While music streaming services have 
evolved to deliver on-demand music for entertainment purposes, 
many stations offer mood-based categories of music. It is unclear 
what criteria are used to choose specific pieces of music for particular 
mood-related categories, and they likely vary among music stream-
ing services. Currently, there is a large diversity of mood-based 
stations, allowing a person to choose from, and listen to, a type 
of music that can affect her/his arousal (activating/deactivating) 
and valence (pleasant/unpleasant). As we describe below, before 
creating novel music libraries and streaming playlists for specific 
clinical purposes, individual pieces of music can be validated for 
their physiological responses using EDA and EEG systems.
Streaming music can modulate arousal and valence in 
people with affective disorders. For example, for patients with 
depression, who may otherwise prefer deactivating and negative-
valence music (38), a long-term and daily stimulation with 
judiciously selected music (e.g., >60–70% of activating/arousal 
and positive/valence content) may produce additional clinical 
benefits. Similarly, for patients with anxiety, a daily streaming 
of calming/relaxing music can stabilize stress hormone levels 
regulated by the hypothalamic–pituitary–adrenal axis (2, 23). For 
people with bipolar disorder during the euthymic stage, a daily 
30-min streaming of balanced activating/deactivating music with 
positive valence may help sustaining homeostasis of emotions 
and prevent relapses. Figure 1B illustrates how music streaming 
services could become adjunct therapies for patients with depres-
sion, anxiety, and bipolar spectrum disorders.
COnVERTinG MUSiC STREAMinG 
SERViCES AnD MOBiLE AppS inTO 
ADJUnCT THERApiES
Repurposing music streaming services into a medical treatment 
includes validation of clinical claims, followed by the regulatory 
clearance/approval for using software as a medical device (exam-
ples of the regulatory agencies include the European Medicines 
Agency or the Food and Drug Administration). In the United 
States, the Food and Drug Administration and the Federal Trade 
Commission ensure that marketing of digital health products is 
validated for specific conditions. Clinical validation of the music-
generating software in randomized controlled trials is necessary 
to support the medical device status (Figure  1B). There are 
several mobile apps and games that have been cleared as medi-
cal device therapies for the patients with diabetes or stroke. To 
the best of our knowledge, there are no published data showing 
clinical efficacy of music streaming services for specific affective 
disorders.
To develop a music streaming service as an adjunct therapy 
for treatment of depression, anxiety, and bipolar spectrum, 
several parameters can be tested in randomized clinical trials, 
such as: (1) judicious selection of music with respect to arousal 
(activation/deactivation) and valence (pleasant/unpleasant), (2) 
total length of the therapy and daily duration of listening, and 
(3) proportion of arousal activating versus deactivating music 
delivered to patients daily and throughout the whole treatment. 
Such system is schematically illustrated in Figure 1B, and the key 
“medical” element is software with the approved medical device 
status. An affective brain–computer music interface provides 
an example of music-generating algorithms that could navigate 
affective trajectories for targeting desirable affective state during 
listening to music (39). Noteworthy, a mobile app delivering cus-
tomized and downloaded music playlist for off-line use can be 
developed as mobile medical app. Coupling music with mobile 
EEG systems or EDA smartwatches offers additional means to 
increase the clinical efficacy of music-streaming by enhancing 
the physiologically active content through biofeedback mecha-
nisms (22, 32, 39, 40).
Many patients with chronic medical conditions (diabetes, 
arthritis, neuropathic pain, schizophrenia, addiction, epilepsy, 
cardiovascular, cancer, and HIV/AIDS) who suffer from depres-
sion as comorbidity could also benefit from the music streaming 
therapies. Broader applications of music-evoked modulation of 
emotions via streaming include post-traumatic stress disorder, 
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attention-deficit/hyperactivity disorder, autism, insomnia, 
neurorehabilitation, neurodegenerative, and developmental dis-
orders. Since internet-based, self-help interventions may support 
prevention of depression (41), preventive medicine indications 
of music streaming may be also appealing for those at risk for 
affective disorders due to genetic, stress, adverse childhood 
experiences, and other environmental factors (42). Applications 
of music streaming can include postoperative pain management, 
given results from randomized trials on music interventions for 
analgesia in adult and pediatric patients (43, 44). When develop-
ing music-streaming medical software, protection of patient’s 
electronic health records, cybersecurity, long-term patient 
engagement (18), as well as unhealthy and maladaptive effects of 
music shall be taken into account (45, 46).
Increasing awareness among artists, music, digital, health care, 
and pharma industries about medical applications of streaming 
music could spur cross-disciplinary efforts toward development 
of low-cost, add-on therapies for chronic medical conditions. 
Given technological advances, biofeedback-based screening of 
already-existing musical tracks can facilitate initial evaluation of 
their clinical utility (47, 48). Analogous to drug discovery efforts 
using high-throughput assays, or virtual screening, collections 
of music can be mined with EEG, or EDA, or computer-based 
algorithms to detect and categorize specific musical structures. 
From the economic perspective, significantly higher revenues 
of pharmaceutical, electronic, and healthcare industries, as 
compared to copyright/music industry, favor mutual benefits of 
collaborative efforts to integrate creative elements into medical 
treatments. Challenges in advancing music streaming as medi-
cal treatments include: (1) differences between a rapid pace of 
technological advancements in consumer electronic industries 
and constant creation of new songs and music, as compared 
to a slower pace of clinical research and regulatory processes, 
(2)  differences in business cultures between music/electronic 
industries and healthcare (profit margins versus the patient safety 
and clinical efficacy), and (3) individual and cultural preferences 
for different genres of music. Since music streaming services 
offer millions of musical tracks, and they constantly update their 
playlist portfolios, the above challenges could be mitigated by: 
(1)  developing clinically effective, music-selecting algorithms 
that are independent of technological, or music content, updates, 
and (2) long-term collaborations between pharma and music 
streaming companies. Clinical validation and regulatory approval 
of music streaming has an incentive of broader acceptance by the 
patients, health-care providers, including potential reimburse-
ments by third-party payers. Integration of music and mobile 
software with pharmacological treatments can lead toward 
development of molecular–behavioral combination therapies via 
drug–device combination products (14, 49). Such strategy also 
expands future portfolio of therapies, in addition to repurposing 
existing drugs, or developing new drugs, which can cost between 
$2 and $3 billion (50). Music streaming has a potential to improve 
health-related quality of life of people living with chronic medical 
conditions, further supporting public health.
COnCLUSiOn
The diversity of cultural origins, music genres, and personal pref-
erences does not impact universal values of music, while music 
therapies have been known for many years. Herein, we describe 
how a rapid growth in internet and mobile technologies, includ-
ing worldwide accessibility of music streaming and smartphones 
can in part address increasing global mental health challenges. 
Repurposing music streaming services into the therapies for 
depression, anxiety, or bipolar spectrum will require cross-disci-
plinary collaborations and rigorous clinical validation of specific 
medical claims. Given convenience and low costs of delivering 
digital interventions, developing music streaming therapies could 
offer new opportunities for patients, their caregivers, health-care 
professionals, music industry, and artists worldwide.
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